Northeast Bradford School District, PA GO Bond Rating Raised To 'A+' Nov 11

  • ID: 1952482
  • November 2011
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) Nov. 14, 2011--Standard & Poor's Ratings Services has raised its underlying rating (SPUR) on Northeast Bradford School District, Pa.'s general obligation (GO) debt to 'A+' from 'A'. The 'A' rating on the district's GO bonds had reflected the security provided by the Pennsylvania State Aid Intercept Program. However, since the unenhanced rating on the district's debt is now 'A+', Standard & Poor's is revising the 'A' SPUR to reflect the higher of the school issuer credit rating (ICR) and the program rating. The outlook is stable. Standard & Poor's also assigned its 'A+' long-term rating and school ICR to the district's $3.57 million series 2011 GO bonds. The 'A+' ratings also reflect Standard & Poor's...

Companies mentioned in this report are: Northeast Bradford Sch Dist
Action: New Rating
Action: Outlook: Stable
Action: Upgraded

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Northeast Bradford Sch Dist

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.